$75.68 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest



STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It manufactures lenses used in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. As of December 29, 2017, the Company sold its products in over 75 countries, with distribution in the United States, Canada, Japan and Spain.

Stock Analysis

last close $75.68
1-mo return 10.3%
3-mo return 5.3%
avg daily vol. 460.5T
52-week high 163.08
52-week low 49.03
market cap. $3.5B
forward pe 121.9
annual div. -
roe 11.9%
ltg forecast -
dividend yield -
annual rev. $243M
inst own. 95.3%

Subscribe now for daily local and international financial news